At the one year mark, Sarepta Therapeutics’ SRP-9001 micro-dystrophin gene therapy continues to show positive results…
Vanessa Pataia
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Vanessa Pataia
PerkinElmer Genomics has launched a new test that is able to accurately detect the…
Researchers have improved a gene editing technique that may more efficiently correct DMD…
The Muscular Dystrophy Association (MDA) has launched its 38th annual…
Registration for the upcoming Parent Project Muscular Dystrophy (PPMD) Advocacy Conference is now open.
Oral treatment with TAS-205 is safe, and may delay muscle deterioration in patients…
Seeking to improve treatment of Duchenne muscular dystrophy (DMD), CureDuchenne has teamed up with…